Preterm Birth Drug Pulled From Market Over Lack of Effectiveness
FDA has been proposing to remove Makena from the market since October 2020, a decision appealed by the drug maker
Preconception Diabetes, Prediabetes Increase Risk for Preterm Birth
Elevated preconception glucose levels highest among women with limited access to and use of health care
Air Pollution Exposure Tied to Bone Loss in Postmenopausal Women
Findings particularly strong between nitrogen oxides exposure and lumbar spine density
Vaginal Erbium YAG Laser Beneficial for Overactive Bladder Syndrome
Improvements seen in total Overactive Bladder Symptom Score, nocturia, urgency, vaginal atrophy symptoms score
Pelvic Floor Pain May Impact Subjective Outcome Measures in Cystitis
However, pelvic floor pain is not tied to bladder conditions among women with interstitial cystitis or bladder pain syndrome
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Study shows that polygenic score does not modify the 13 percent reduction in ovarian cancer risk seen with aspirin
Risk for Interpersonal Violence Up for Pregnant People With Schizophrenia
Findings seen during perinatal period, with increased relative risks during pregnancy period and first year postpartum
High Cardiovascular Health Tied to Longer Life Expectancy Free of Disease
For those with high cardiovascular health level, no significant difference seen in disease-free life expectancy based on socioeconomic status
FDA Panel to Again Weigh Merit of Decongestant That Many Call Useless
Agency's Nonprescription Drugs Advisory Committee will meet in April to consider the effectiveness of the oral version of phenylephrine
Walgreens Will Not Sell Abortion Pills in 20 Republican States
More than half of U.S. abortions in 2020 were completed by medication instead of surgery
